<?xml version="1.0" encoding="UTF-8"?>
<ref id="B91">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lalezari</surname>
    <given-names>J. P.</given-names>
   </name>
   <name>
    <surname>Henry</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>O’Hearn</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Montaner</surname>
    <given-names>J. S.</given-names>
   </name>
   <name>
    <surname>Piliero</surname>
    <given-names>P. J.</given-names>
   </name>
   <name>
    <surname>Trottier</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2003</year>). 
  <article-title>Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.</article-title>
  <source>
   <italic>N. Engl. J. Med.</italic>
  </source>
  <volume>348</volume>
  <fpage>2175</fpage>–
  <lpage>2185</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa035026</pub-id>
  <pub-id pub-id-type="pmid">12637625</pub-id>
 </mixed-citation>
</ref>
